MedPath

Assessing Dutch-language versions of two questionnaires design to assess the impact of side effects of radiotherapy in patients with head and neck cancer

Not Applicable
Completed
Conditions
Patients treated with (adjuvant) radiotherapy for head and neck cancer
Cancer
Registration Number
ISRCTN49549338
Lead Sponsor
Antwerp University Hospital
Brief Summary

2022 Results article in https://dx.doi.org/10.5152/B-ENT.2022.22989 Results for D-OMWQ-HN (added 02/11/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
75
Inclusion Criteria

1. Patients with head and neck cancer treated with radiotherapy or chemoradiotherapy
2. Tumor located in the oral cavity, oropharynx, nasopharynx, hypopharynx or larynx
3. Aged 18 years or older

Exclusion Criteria

1. Patients treated with experimental medication used for oral mucositis
2. Cognitive problems

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath